-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Furosemide in Congestive Heart Failure (Heart Failure)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Furosemide in Congestive Heart Failure (Heart Failure) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Furosemide in Congestive Heart Failure (Heart Failure) Drug...
-
Product Insights
NewPrime Discoveries Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Prime Discoveries Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Prime Discoveries Inc (Prime Discoveries) develops rapid, novel diagnostics for pathogen infections. Prime Discoveries is headquartered in New York City, New York, the US. GlobalData's Medical Devices company profile report, “Prime Discoveries Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile report provides key information and...
-
Product Insights
NewClick Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Click Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Click Therapeutics Inc (Click Therapeutics) is a biotechnology company that provides mobile software applications that treat disease. It develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. Click Therapeutics is headquartered in New York City, New York, the US. GlobalData's Medical Devices company profile report, “Click Therapeutics Inc Pipeline Insight and Competitive Landscape,...
-
Product Insights
NewIntelligent Bio Solutions Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Intelligent Bio Solutions Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Intelligent Bio Solutions Inc (Intelligent) is a medical equipment company that provides diagnostic and testing equipment for diabetes. The company is Headquartered in New York City, New York, the US. GlobalData's Medical Devices company profile report, “Intelligent Bio Solutions Inc Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products....
-
Product Insights
NewSoterix Medical Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Soterix Medical Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Soterix Medical Inc (Soterix Medical) is a biopharmaceutical company that develops medical devices and accessories focused on neuropsychiatric and neurological disorders and rehabilitation. It specialized in non-invasive neuromodulation and integrated brain monitoring technology solutions. The company is headquartered in New York City, New York, the US. GlobalData's Medical Devices company profile report, “Soterix Medical Inc Pipeline Insight and Competitive...
-
Company Insights
The Bank of New York Mellon Corporation – Digital Transformation Strategies
BNY Mellon Digital Transformation Strategies Overview Bank of New York Mellon Corp (BNY Mellon) is leveraging AI and big data technologies as a part of its digital transformation strategies. The annual ICT spending of BNY Mellon was estimated at $1.5 billion in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and network and communications from vendors. BNY Mellon is a provider of investment solutions. Its portfolio of offerings consists of investment services, assets servicing,...
-
Product Insights
NewZetaGen Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our ZetaGen Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. ZetaGen Therapeutics Inc (ZetaGen) is an early stage regenerative medicine company focused on the development of bone growth products for the treatment of bone-related injuries, procedures and diseases. Its lead product ZetaFuse, a drug-device combination product is built on small molecule-based osteogenic technology platform. ZetaGen facilitates bone regeneration in osteoblasts (osteoinductive), prevents bone resorption (anti-osteolytic) and stops tumor cell...
-
Product Insights
NewPavmed Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Pavmed Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Pavmed Inc (Pavmed) is a medical device company. It offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube. Pavmed’s product pipeline also comprises NextCath, a self-anchoring...
-
Product Insights
NewStarton Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Starton Therapeutics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Starton Therapeutics Inc (Starton), formerly ChemioCare USA Inc, is a biotechnology company that discovers and develops drugs for the treatment of hematological malignancies. The company is investigating Star-LLD to treat chronic lymphocytic leukemia (CLL) and multiple myeloma (MM). It is also evaluating STAR-OLZ, to control PARP inhibitor and chemotherapy induced nausea and vomiting; and STAR- RK against nerve disorders....
-
Product Insights
NewNemaura Medical Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Nemaura Medical Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Nemaura Medical Inc (Nemaura Medical) is a medical technology company that focuses on developing sugarBEAT, a non-invasive and flexible continuous glucose monitoring system for the treatment of patients with diabetes and Miboko, a noninvasive glucose sensor. Nemaura Medica technology comprises digital solutions for weight loss and potential reversal of type 2 diabetes and pre-diabetes, glucose monitoring, continuous lactate monitoring...